• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过肺康复和药物治疗改善慢性阻塞性肺疾病患者的身体活动能力。

Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment.

作者信息

Shioya Takanobu, Sato Susumu, Iwakura Masahiro, Takahashi Hitomi, Terui Yoshino, Uemura Sachiko, Satake Masahiro

机构信息

Akita University Graduate School of Health Sciences, Department of Physical Therapy, Akita, Japan.

Kyoto University Hospital, Department of Rehabilitation & Pulmonary Medicine, Kyoto, Japan.

出版信息

Respir Investig. 2018 Jul;56(4):292-306. doi: 10.1016/j.resinv.2018.05.002. Epub 2018 Jun 11.

DOI:10.1016/j.resinv.2018.05.002
PMID:29903607
Abstract

Physical activity (PA) is defined as bodily movement produced by skeletal muscles with energy expenditure beyond resting levels. PA is closely related to reduced morbidity and mortality in chronic obstructive pulmonary disease (COPD). Self-report questionnaires are often subject to recall bias, correlating poorly with objectively qualified PA, and do not provide an accurate estimate of free-living energy expenditure. PA may be objectively evaluated by newly developed tri-axial accelerometers by quantifying steps or body movements over a period of time. Low-intensity, home-based pulmonary rehabilitation (PR) using pedometer feedback improves PA. Improvement in physiological factors correlates with increased walking time in stable elderly COPD patients. This review focuses on the effects of PR and pharmacological treatment on PA in COPD patients. We selected 32 studies from our literature search evaluating the effects of PR and 11 studies examining the effects of pharmacological treatment on PA. Findings in both categories were inconsistent. Nineteen studies showed a positive effect with PR whereas 13 showed no effect. Eight studies showed a positive effect, while three revealed no effect from pharmacological intervention. As both interventions increase exercise capacity without a consistent effect on PA, counseling with behavioral changes may be necessary to achieve a significant and lasting increase in PA. Changing PA behavior in COPD patients requires an interdisciplinary approach involving specialists in respiratory medicine, rehabilitation, social, and behavioral sciences. Future research in this area is warranted to advance our knowledge in this area, specifically with regard to the interaction of pharmacological and non-pharmacological interventions.

摘要

身体活动(PA)被定义为骨骼肌产生的、能量消耗超过静息水平的身体运动。PA与慢性阻塞性肺疾病(COPD)发病率和死亡率的降低密切相关。自我报告问卷常常存在回忆偏倚,与客观测定的PA相关性较差,并且不能准确估计日常活动中的能量消耗。可以通过新开发的三轴加速度计,通过量化一段时间内的步数或身体运动来客观评估PA。使用计步器反馈的低强度居家肺康复(PR)可改善PA。在稳定的老年COPD患者中,生理因素的改善与步行时间的增加相关。本综述重点关注PR和药物治疗对COPD患者PA的影响。我们从文献检索中筛选出32项评估PR效果的研究以及11项研究药物治疗对PA影响的研究。这两类研究的结果均不一致。19项研究显示PR有积极效果,而13项研究显示无效果。8项研究显示药物干预有积极效果,而3项研究显示无效果。由于这两种干预措施都能提高运动能力,但对PA没有一致的影响,因此可能需要进行行为改变咨询,以实现PA的显著且持久的增加。改变COPD患者的PA行为需要一种跨学科方法,涉及呼吸医学、康复、社会和行为科学方面的专家。该领域未来的研究有必要推进我们在这方面的知识,特别是关于药物和非药物干预措施之间的相互作用。

相似文献

1
Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment.通过肺康复和药物治疗改善慢性阻塞性肺疾病患者的身体活动能力。
Respir Investig. 2018 Jul;56(4):292-306. doi: 10.1016/j.resinv.2018.05.002. Epub 2018 Jun 11.
2
[Improvement of physical activity in patients with COPD].[慢性阻塞性肺疾病患者身体活动能力的改善]
Nihon Rinsho. 2016 May;74(5):843-9.
3
Glycopyrronium + indacaterol. A fixed-dose combination with no advantages in COPD.格隆溴铵+茚达特罗。一种固定剂量复方制剂,对慢性阻塞性肺疾病无优势。
Prescrire Int. 2014 Dec;23(155):288.
4
Effects of low-intensity exercise and home-based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with chronic obstructive pulmonary disease.低强度运动及基于家庭的带计步器反馈的肺康复对老年慢性阻塞性肺疾病患者身体活动的影响
Respir Med. 2015 Mar;109(3):364-71. doi: 10.1016/j.rmed.2015.01.008. Epub 2015 Jan 29.
5
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.慢性阻塞性肺疾病的症状变异性与控制:双重支气管扩张疗法的优势
Respir Med. 2017 Apr;125:49-56. doi: 10.1016/j.rmed.2017.03.001. Epub 2017 Mar 2.
6
Glycopyrrolate/formoterol (Bevespi Aerosphere) for COPD.格隆溴铵/福莫特罗(倍氯米松气雾剂)用于慢性阻塞性肺疾病。
Med Lett Drugs Ther. 2016 Oct 10;58(1505):130-132.
7
Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.吸入用格隆溴铵单药治疗以及与马来酸茚达特罗固定剂量联合治疗慢性阻塞性肺疾病的概况
Int J Chron Obstruct Pulmon Dis. 2015 Jan 7;10:111-23. doi: 10.2147/COPD.S67758. eCollection 2015.
8
[The combination of indacaterol and glycopyrronium has effects on symptoms, lung function, and rate of exacerbations in COPD patients].茚达特罗与格隆溴铵联合使用对慢性阻塞性肺疾病(COPD)患者的症状、肺功能及急性加重率有影响。
Ugeskr Laeger. 2014 Sep 15;176(38).
9
Seebri Neohaler and Utibron Neohaler for COPD.用于慢性阻塞性肺疾病(COPD)的思力华能倍乐和欧乐欣能倍乐。
Med Lett Drugs Ther. 2016 Mar 28;58(1491):39-41.
10
GFF MDI for the improvement of lung function in COPD - A look at the PINNACLE-1 and PINNACLE-2 data and beyond.用于改善慢性阻塞性肺疾病(COPD)肺功能的全球创新药物(GFF)干粉吸入器——审视PINNACLE-1和PINNACLE-2数据及其他相关数据
Expert Rev Clin Pharmacol. 2017 Jul;10(7):685-698. doi: 10.1080/17512433.2017.1320218. Epub 2017 May 2.

引用本文的文献

1
The association between physical activity and lung function in adolescents: a cross-sectional NHANES study.青少年身体活动与肺功能之间的关联:一项横断面美国国家健康与营养检查调查(NHANES)研究
Front Med (Lausanne). 2025 Jun 3;12:1538221. doi: 10.3389/fmed.2025.1538221. eCollection 2025.
2
Utility of the Shortness of Breath in Daily Activities Questionnaire (SOBDA-Q) to Detect Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease (COPD).日常活动气短问卷(SOBDA-Q)在检测慢性阻塞性肺疾病(COPD)患者久坐行为方面的效用。
J Clin Med. 2023 Jun 17;12(12):4105. doi: 10.3390/jcm12124105.
3
Objective Measurement of Physical Activity and Sedentary Behavior in Patients with Chronic Obstructive Pulmonary Disease: Points to Keep in Mind during Evaluations.
慢性阻塞性肺疾病患者身体活动和久坐行为的客观测量:评估过程中需牢记的要点
J Clin Med. 2023 May 2;12(9):3254. doi: 10.3390/jcm12093254.
4
Prediction of Low-intensity Physical Activity in Stable Patients with Chronic Obstructive Pulmonary Disease.稳定期慢性阻塞性肺疾病患者低强度体力活动的预测
Phys Ther Res. 2022;25(3):143-149. doi: 10.1298/ptr.E10208. Epub 2022 Dec 22.
5
Associations of pulmonary and extrapulmonary computed tomographic manifestations with impaired physical activity in symptomatic patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病有症状患者的肺部和肺外计算机断层扫描表现与体力活动受损的相关性。
Sci Rep. 2022 Apr 4;12(1):5608. doi: 10.1038/s41598-022-09554-6.
6
Self-Efficacy Intervention Programs in Patients with Chronic Obstructive Pulmonary Disease: Narrative Review.慢性阻塞性肺疾病患者的自我效能干预方案:叙事性综述。
Int J Chron Obstruct Pulmon Dis. 2021 Dec 18;16:3397-3403. doi: 10.2147/COPD.S338720. eCollection 2021.
7
First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease.噻托溴铵/奥达特罗一线治疗可改善初治慢性阻塞性肺疾病患者的身体活动能力。
Int J Chron Obstruct Pulmon Dis. 2020 Sep 14;15:2115-2126. doi: 10.2147/COPD.S268905. eCollection 2020.
8
Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy.在意大利的常规临床实践中,接受噻托溴铵/奥达特罗吸入喷雾剂治疗的慢性阻塞性肺疾病患者的身体功能
Pulm Ther. 2020 Dec;6(2):261-274. doi: 10.1007/s41030-020-00122-9. Epub 2020 Jun 18.
9
Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients.噻托溴铵/奥达特罗改善中、东欧 COPD 患者的自我报告身体机能
Int J Chron Obstruct Pulmon Dis. 2019 Oct 11;14:2343-2354. doi: 10.2147/COPD.S204388. eCollection 2019.
10
Simple standard equation for daily step count in Japanese patients with chronic obstructive pulmonary disease.日本慢性阻塞性肺疾病患者日常步数的简单标准方程。
Int J Chron Obstruct Pulmon Dis. 2019 Aug 30;14:1967-1977. doi: 10.2147/COPD.S218705. eCollection 2019.